← Back to explorer

Suministro de Medicamento Ublituximab 150 mg vial (BRIUMVI) de distribución exclusiva del Laboratorio Neuraxpharm Spain S.L con destino al Servicio de Farmacia del Hospital Clínico San Carlos

TED · 323886-2026can-standardawardedNo deadline given

Buyer

NameHOSPITAL CLINICO SAN CARLOS

CountryES

Published2026-05-12

Deadline

Value

Estimated€391,541 · 391,540.51 EUR

Awarded€177,973 · 177,972.96 EUR

WinnerLABORATORIO NEURAXPHARM SPAIN S.L.

See this firm's wins →

CPV codes

33600000 Medical equipment & pharmaceuticals

Description

Suministro de Medicamento Ublituximab 150 mg vial (BRIUMVI) de distribución exclusiva del Laboratorio Neuraxpharm Spain S.L con destino al Servicio de Farmacia del Hospital Clínico San Carlos

Source

View the official notice on TED